Document:

Exhibit 10.10

 

MOSAIC IMMUNOENGINEERING INC.

2020 OMNIBUS INCENTIVE PLAN

 

NOTICE OF STOCK APPRECIATION RIGHTS

 

Mosaic ImmunoEngineering
Inc., a Delaware corporation (the “Company”) grants to you the following Stock Appreciation Rights (“SARs”),
pursuant to the Company’s 2020 Omnibus Incentive Plan (the “Plan”) and the attached Stock Appreciation Rights
Award Agreement (the “Award Agreement”):

 

	Participant:	[insert name]

 

	Total Number of SARs:	[insert number of shares]

 

	Form of SARs:	[insert Tandem/Freestanding/Combination]

 

	Date of Grant:	[insert date]

 

	Grant Price per Share:	[insert Fair Market Value as of Date of Grant]

 

	Vesting Commencement Date:	[insert Vesting Commencement Date]

 

	Vesting Schedule:	[insert Vesting Schedule]

 

	Final Exercise Date:	[insert Final Exercise Date]. The SARs may expire earlier pursuant to Section 2 of the Award Agreement if the Participant’s
relationship with the Company is terminated, or pursuant to Section VI of the Plan.

 

 

 

 

 

 

 

 

 

    	 	1	 

     

    

 

MOSAIC IMMUNOENGINEERING INC.

2020 OMNIBUS INCENTIVE PLAN

 

Stock Appreciation Rights Award Agreement

 

Dear [insert name]:

 

On [insert date], the Committee approved
a grant of Stock Appreciation Rights (“SARs”) to you with respect to Shares of common stock of Mosaic ImmunoEngineering
Inc. (the “Company”) pursuant to the Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan (the “Plan”).
The SARs shall constitute and be treated at all times by you and the Company as [Freestanding SARs/Tandem SARs/combination of Freestanding
SARs and Tandem SARs]. Capitalized terms not defined in this Award Agreement shall have the meaning set forth in the Plan and the
attached Notice of Stock Appreciation Rights (the “Notice”).

 

You are granted [insert amount] SARs of
the Company, with [all SARs being Freestanding SARs/Tandem SARs / with [insert amount] being Freestanding SARs and [insert amount]
being Tandem SARs]. The Date of Grant is [insert date] and the Fair Market Value of a Share of common stock of the Company as of
such date is the Grant Price.

 

1.       Vesting.
Subject to your not incurring a Separation from Service with the Company prior to the applicable vesting dates, the SARs shall
vest and become exercisable at the time or times set forth in the Notice.

 

The Committee may accelerate
the vesting of SARs in the event of a Change in Control, as defined in the Plan, provided that such vesting and exercisability
is conditioned on the consummation of such Change in Control and either (i) the Participant’s service with the Company is
terminated (except a termination for Cause, as defined in the Plan) in connection with, or within 24 months after, a Change in
Control, or (ii) the Committee or the Board determines that (A) such outstanding SARs will not be continued, assumed, converted
and/or substituted, or (B) it is in the best interests of the Company to vest such outstanding SARs.

 

2.       Duration
of SARs. SARs may be exercised at any point in time between the Vesting Date and the Final Exercise Date set forth in the Notice.
Except as otherwise provided herein, the SARs may be exercised for three (3) months after you incur a Separation from Service from
the Company; provided, however, in the event your Separation from Service is due to your death or Disability, the SARs may be exercised
for one year following such event. If, prior to the Final Exercise Date set forth in the Notice, you incur a Separation from Service
for Cause (as defined below), the right to exercise the SARs shall terminate immediately upon the effective date of such Separation
from Service. If you are a party to an agreement with the Company that contains an applicable definition of “cause,”
“Cause” shall have the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean willful
misconduct or willful failure to perform your responsibilities to the Company (including, without limitation, breach of any provision
of any employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between you and the Company),
as determined by the Company, which determination shall be conclusive. You shall be considered to have been discharged for “Cause”
if the Company determines, within 30 days after your resignation, that discharge for “Cause” was warranted.

 

3.       Exercise
of SARs. Upon exercise (by delivery of an Exercise Notice, in the form attached as Exhibit A), and subject to applicable tax
withholding, you will be entitled to receive payment from the Company in an amount determined by multiplying (a) the difference
between the Fair Market Value of a Share of common stock of the Company on the exercise date and the Grant Price, by (b) the number
of Shares with respect to which the SAR is exercised. This amount will be paid to you in [cash/shares/combination].

 

If you are an Employee, you acknowledge
and agree that applicable tax withholding shall be accomplished by having the Company withhold Shares having a fair market value
equal to the minimum statutory total tax obligations.

 

 

 

 

    	 	2	 

     

    

 

4.       Non-Assignability
of SARs. The SARs may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated, other than by will
or by the laws of descent or distribution and may be exercised during your lifetime only by you except in the case of your Disability,
the SARs may be exercised by your representative. The terms of the Plan and this Award Agreement shall be binding upon your executors,
administrators, heirs, successors and assigns.

 

5.       Code
Section 409A. The Grant Price is intended to be not less than the Fair Market Value of the common stock of the Company on the
Date of Grant. The Company has determined the Fair Market Value of the common stock of the Company in good faith and using the
reasonable applicable of a reasonable valuation method, for purposes of determining the Grant Price. Notwithstanding this, the
Internal Revenue Service may assert that the Fair Market Value of the common stock of the Company on the Date of Grant was greater
than the Grant Price. Under Code Section 409A, if the Grant Price is less than the Fair Market Value of the common stock of the
Company on the Date of Grant, the SARs may be treated as a form of deferred compensation and you may be subject to an additional
twenty percent (20%) tax, plus interest and possible penalties. You hereby acknowledge that the Company has advised you to consult
with a tax advisor regarding the potential impact of Code Section 409A and that the Company, in the exercise of its sole discretion
and without your consent, may amend or modify this Award Agreement in any manner and delay the payment of any amounts payable pursuant
to this Award Agreement to the minimum extent necessary to meet the requirements of Code Section 409A, as amplified by any Internal
Revenue Service or U.S. Treasury Department regulations or guidance as the Company deems appropriate or advisable.

 

You have reviewed with your own tax advisors
the federal, state, local and foreign tax consequences of this Award Agreement. You are relying solely on such advisors and not
on any statements or representations of the Company or any of its agents. You understand that you (and not the Company) shall be
responsible for your own tax liability that may arise as a result of this Award Agreement.

 

6.       No
Guarantee of Continued Service. YOU ACKNOWLEDGE AND AGREE THAT THE VESTING OF SARs PURSUANT TO THE VESTING SCHEDULE SET FORTH
HEREIN ARE EARNED ONLY BY CONTINUING SERVICE AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THE
SARs OR ACQUIRING SHARES HEREUNDER). YOU FURTHER ACKNOWLEDGE AND AGREE THAT THIS AWARD AGREEMENT, THE TRANSACTIONS CONTEMPLATED
HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED SERVICE FOR THE
VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE IN ANY WAY WITH YOUR RIGHT OR THE COMPANY’S RIGHT TO TERMINATE
YOUR SERVICE WITH OR WITHOUT CAUSE.

 

The SARs granted to you are subject to
and governed by the terms of the Plan which is incorporated by reference and a copy is attached hereto. The Plan and this Award
Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety
all prior undertakings and agreements of the Company and you with respect to the subject matter hereof, and may not be modified
adversely to your interest except by means of a writing signed by the Company and you. This Award Agreement is governed by the
laws of the State of California.

 

By your signature and the signature of
the Company's representative below, you and the Company agree that this SAR is granted under and governed by the terms and conditions
of the Plan and this Award Agreement. You have reviewed the Plan and this Award Agreement in their entirety, have had an opportunity
to obtain the advice of counsel prior to executing this Award Agreement and fully understand all provisions of the Plan and this
Award Agreement. You hereby agree to accept as binding, conclusive and final all decisions or interpretations of the Committee
upon any questions relating to the Plan and Award Agreement. You further agree to notify the Company upon any change in your residence
address indicated below.

 

 

	PARTICIPANT	 	MOSAIC IMMUNOENGINEERING INC.
	 	 	 
	 	 	 
	Signature	 	By
	 	 	 
	 	 	 
	Print Name	 	Title
	 	 	 
	 	 	 
	Residence Address	 	 
	 	 	 
	  
	 	 

 

 

    	 	3	 

     

    

 

Exhibit A

EXERCISE NOTICE

OF STOCK APPRECIATION RIGHTS

 

Mosaic ImmunoEngineering Inc.

 

 

------------------------

(date)

 

Re: Stock Appreciation Rights

 

Notice is hereby given pursuant to Section
3 of my Stock Appreciation Rights Award Agreement that I elect to exercise the number of stock appreciation rights set forth below
at the exercise price set forth in my Stock Appreciation Rights Award Agreement:

 

	 	Stock Appreciation Rights dated:	 	 
	 	 	 	 
	 	Number of SARs being exercised:	 	 
	 	 	 	 
	 	Grant Price:	 	 

 

I understand that the Shares of common
stock of the Company that I may receive upon exercise of my Stock Appreciation Rights may not be freely tradable.

 

Further, I understand that, as a result
of this exercise of rights, I will recognize income in an amount equal to the amount by which the fair market value of the Shares
of common stock of the Company exceeds the exercise price. I agree to report such income in accordance with then applicable law
and to cooperate with the Company in establishing the withholding and corresponding deduction to the Company for its income tax
purposes.

 

I agree to provide to the Company such
additional documents or information as may be required pursuant to the Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan.

 

 

--------------------------------------------

          (Signature)

--------------------------------------------

          (Name of Participant)

 

 

 

 

 

 

    	 	4Exhibit 10.11

 

FORM OF INDEMNIFICATION
AGREEMENT

 

This Indemnification
Agreement (“Agreement”) is made as of [_______], by and between Mosaic ImmunoEngineering Inc., a Delaware
corporation (the “Company”), and [________], (“Indemnitee”).

 

RECITALS

 

WHEREAS, highly
competent persons have become more reluctant to serve publicly held corporations as directors, officers, consultants or in other
capacities unless they are provided with adequate protection through insurance or adequate indemnification against inordinate risks
of claims and actions against them arising out of their service to and activities on behalf of the Company;

 

WHEREAS, the
Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified
individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons
serving the Company and its subsidiaries from certain liabilities. Although the furnishing of such insurance has been a customary
and widespread practice among United States-based corporations and other business enterprises, the Company believes that, given
current market conditions and trends, such insurance may be available to it in the future only at higher premiums and with more
exclusions. At the same time, directors, officers, consultants, and other persons in service to corporations or business enterprises
are being increasingly subjected to expensive and time-consuming litigation relating to, among other things, matters that traditionally
would have been brought only against the Company or business enterprise itself. The Amended and Restated Certificate of Incorporation
(“Certificate of Incorporation”) of the Company provides that the Company may indemnify the officers and directors
of the Company. Indemnitee may also be entitled to indemnification pursuant to the Delaware General Corporation Law (“DGCL”).
The Certificate of Incorporation and the DGCL expressly provide that the indemnification provisions set forth therein are not exclusive,
and thereby contemplate that contracts may be entered into between the Company and members of the board of directors, officers,
consultants, and other persons with respect to indemnification;

 

WHEREAS, the
uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such
persons;

 

WHEREAS, the
Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests
of the Company’s stockholders and that the Company should act to assure such persons that there will be increased certainty
of such protection in the future;

 

WHEREAS, it
is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on
behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company
free from undue concern that they will not be so indemnified;

 

WHEREAS, this
Agreement is a supplement to and in furtherance of the Certificate of Incorporation of the Company and any resolutions adopted
pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

 

WHEREAS, Indemnitee
is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that
he be so indemnified.

 

 

 

 

    	 	1	 

     

    

 

NOW, THEREFORE,
in consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as
follows:

 

Section 1. Services
to the Company. The Indemnitee agrees to serve or continue to serve as a director and/or officer of the Company for so long
as the Indemnitee is duly elected or appointed or until such time as the Indemnitee tenders a resignation in writing.

 

Section 2. Definitions.
As used in this Agreement:

 

(a) “Access Period”
mean the period commencing on the date Indemnitee first became an Officer or member of the Board of the Company and ending on the
date this Agreement is terminated in accordance with Section 14 hereof.

 

(b) “Board Papers”
means all materials provided to Indemnitee specifically in connection with any meeting of the Board or any committee of the Board,
whether in documentary form or some other form, including, but not limited to, board papers, submissions, minutes, memoranda, legal
opinions, financial statements and subcommittee papers during the Relevant Period.

 

(c) A “Change
in Control” shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following
events:

 

i. Acquisition
of Stock by Third Party. Any Person (as defined below) is or becomes the Beneficial Owner (as defined below), directly or indirectly,
of securities of the Company representing twenty percent (20%) or more of the combined voting power of the Company’s then
outstanding securities;

 

ii. Change
in Board of Directors. During any period of two (2) consecutive years (not including any period prior to the execution of this
Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated
by a person who has entered into an agreement with the Company to effect a transaction described in Sections 2(c)(i), 2(c)(iii),
or 2(c)(iv) whose election by the Board or nomination for election by the Company’s stockholders was approved by a
vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose
election or nomination for election was previously so approved, cease for any reason to constitute a least a majority of the members
of the Board;

 

iii. Corporate
Transactions. The effective date of a merger or consolidation of the Company with any other entity, other than a merger or
consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation
continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity)
more than 80% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such
merger or consolidation and with the power to elect at least a majority of the board of directors or other governing body of such
surviving entity;

 

iv. Liquidation.
The approval by the stockholders of the Company of a complete liquidation of the Company or an agreement for the sale or disposition
by the Company of all or substantially all of the Company’s assets; and

 

v. Other
Events. There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule
14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the Exchange Act (as
defined below), whether or not the Company is then subject to such reporting requirement.

 

 

 

 

    	 	2	 

     

    

 

For purposes of Section
2(c)(i) and Section 2(c)(v) of this Agreement, the following terns shall have the following meanings:

 

(A) “Exchange Act” shall
mean the Securities Exchange Act of 1934, as amended.

 

(B) “Person” shall have the
meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act; provided, however, that Person shall exclude
(i) the Company, (ii) any trustee or other fiduciary holding securities under an employee benefit plan of the Company, and (iii)
any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their
ownership of stock of the Company.

 

(C) “Beneficial Owner” shall
have the meaning given to such term in Rule 13d-3 under the Exchange Act; provided, however, that Beneficial Owner shall exclude
any Person otherwise becoming a Beneficial Owner by reason of the stockholders of the Company approving a merger of the Company
with another entity.

 

(d) “Corporate
Status” describes the status of a person who is or was, or has agreed to become, a director, officer, employee, consultant
or agent of the Company or of any other corporation, limited liability company, partnership or joint venture, trust, employee benefit
plan or other enterprise which such person is or was serving at the request of the Company.

 

(e) “Director
Indemnitee” means, for purposes of Section 12(f) of this Agreement, an Indemnitee who is or was a director of the
Company as of the date of this Agreement or who hereafter becomes a director of the Company prior to the termination of this Agreement.

 

(f) “Disinterested
Director” means a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification
is sought by Indemnitee.

 

(g) “Enterprise”
shall mean the Company and any other corporation, limited liability company, partnership, joint venture, trust, employee benefit
plan or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, employee,
consultant, agent or fiduciary.

 

(h) “Expenses”
shall include, without limitation, all reasonable attorneys’ fees, retainers, court costs, transcript costs, fees of experts,
witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees,
and all other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing
to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise being involved in, a Proceeding. Expenses
also shall include Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation
the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent.
Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.
Notwithstanding the above, Expenses shall also include amounts incurred to obtain or enforce the Indemnitee’s right to indemnification
or advancement under this Agreement.

 

(i) “Independent
Counsel” means a law firm, or a member of a law firm, selected by the Indemnitee and approved by the Company (which approval
should not be unreasonably withheld or delayed) who, in the past five years has not been retained to represent the Company or Indemnitee
in any matter material to either such party (other than with respect to matters concerning the Indemnitee under this Agreement,
or of other indemnitees under similar indemnification agreements). Notwithstanding the foregoing, the term “Independent Counsel”
shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict
of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement.
The Company agrees to pay the reasonable fees and expenses of the Independent Counsel referred to above and to fully indemnify
such counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its
engagement pursuant hereto.

 

 

 

 

    	 	3	 

     

    

 

(j) A “Potential
Change in Control” shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following
events:

 

i. Agreement
Relating to Change in Control. The Company enters into an agreement, the consummation of which would result in the occurrence
of a Change in Control;

 

ii. Public
Announcement Relating to Change in Control. Any Person (including the Company) publicly announces an intention to take or to
consider taking actions which if consummated would constitute a Change in Control;

 

iii. Acquisition
of Stock by Third Party. Any Person (other than (i) the Company or any of its subsidiaries, or (ii) any pension, profit sharing,
employee stock ownership or other employee benefit plan of the Company or any of its subsidiaries or any trustee of or fiduciary
with respect to any such plan when acting in such capacity) who is or becomes the Beneficial Owner of ten percent (10%) or more
of the combined voting power of the Company’s then outstanding securities, increases his, her or its Beneficial Ownership
of such combined voting power by five percent (5%) or more over the percentage so owned by such Person on the date hereof; or

 

iv. Board
Declaration. The Board adopts a resolution to the effect that, for purposes of this Agreement, a Potential Change in Control
has occurred.

 

(k) The term “Proceeding”
shall include any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, administrative
or regulatory hearing, any formal or informal inquiry, hearing or investigation or any other actual, threatened or completed proceeding
or investigation whether brought in the right of the Company or otherwise and whether of a civil, criminal, administrative, regulatory,
investigative or other nature, and any appeal therefrom.

 

(1) “Relevant
Period” means the period commencing on the date that Indemnitee first became a member of the Board of the Company or consultant
of Company and ending on the date Indemnitee ceases to serve as a member of the Board or on the date the consultant terminates
his agreement.

 

(m) Reference to “other
enterprise” shall include employee benefit plans; references to “fines” shall include any excise tax assessed
with respect to any employee benefit plan; references to “serving at the request of the Company” shall include any
service as a director, officer, employee, consultant, or agent of the Company which imposes duties on, or involves services by,
such director, officer, employee, consultant, or agent with respect to an employee benefit plan, its participants or beneficiaries;
and a person who acted in good faith and in a manner he reasonably believed to be in the best interests of the participants and
beneficiaries of an employee benefit plan shall be deemed to have acted in manner “not opposed to the best interests of the
Company- as referred to in this Agreement.

 

Section 3. Indemnity
of Indemnitee. Subject to Sections 6, 8 and 9, the Company shall indemnify the Indemnitee in connection
with any Proceeding as to which the Indemnitee was, is or is threatened to be made a party to, a witness to or is otherwise involved
by reason of the Indemnitee’s Corporate Status, or by reason of any action alleged to have taken or omitted in connection
therewith, to the fullest extent permitted by law or as may hereafter be amended or interpreted (but in the case of any such amendment
or interpretation, only to the extent that such amendment of interpretation permits the Company to provide broader indemnification
rights than were permitted thereto). The parties hereto intend that this Agreement shall provide for indemnification in excess
of that expressly permitted by statute, including, without limitation, any indemnification provided by the Certification of Incorporation,
the Bylaws, vote of its stockholders or disinterested directors or applicable law. In furtherance of the foregoing and without
limiting the generality thereof:

 

 

 

 

    	 	4	 

     

    

 

(a) Indemnity in Third-Party Proceedings.
The Company shall indemnify Indemnitee in accordance with the provisions of this Section 3(a) if Indemnitee was, is, or
is threatened to be made a party to, a witness to, or is otherwise involved in any Proceeding, (other than a Proceeding by or in
the right of the Company to procure a judgment in its favor or a Proceeding referred to in Section 3(b) below) by reason
of the Indemnitee’s Corporate Status or by reason of any action alleged to have taken or omitted in connection therewith,
against all Expenses, judgments, fines, and amounts paid in settlement actually and reasonably incurred by Indemnitee or on his
behalf in connection with such Proceeding, if Indemnitee acted in good faith and in a manner he reasonably believed to be in, or
not opposed to, the best interests of the Company and, in the case of a criminal Proceeding had no reasonable cause to believe
that his conduct was unlawful.

 

(b) Indemnity in Proceedings by or
in the Right of the Company. The Company shall indemnify Indemnitee in accordance with the provisions of this Section 3(b)
if Indemnitee was, is, or is threatened to be made a party to, a witness to or otherwise involved in any Proceeding by or in the
right of the Company to procure a judgment in its favor by reason of the Indemnitee’s Corporate Status or by reason of any
action alleged to have taken or omitted in connection therewith, against all Expenses and, to the fullest extent permitted by law,
amounts paid in settlement actually and reasonably incurred by or on behalf of the Indemnitee in connection with such Proceeding
if the Indemnitee acted in good faith and in a manner he reasonably believed to be in, or not opposed to, the best interests of
the Company, except that, if the applicable law so provides, no indemnification for Expenses shall be made under this Section
3(b) in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court to be liable
to the Company, unless and only to the extent that the Delaware Court of Chancery or any court in which the Proceeding was brought
shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case,
Indemnitee is fairly and reasonably entitled to indemnification for such Expenses as the Court of Chancery or such other court
shall deem proper.

 

Section 4. Indemnification
for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provisions of this Agreement and to the
fullest extent permitted by applicable law, to the extent that Indemnitee is successful on the merits or otherwise in defense of
any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the Company shall indemnify Indemnitee
against all Expenses actually and reasonably incurred by him in connection therewith. For purposes of this Section 4 and
without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice,
shall be deemed to be a successful result as to such claim, issue or matter.

 

Section 5. Indemnification
For Expenses of a Witness. Notwithstanding any other provision of this Agreement, to the fullest extent permitted by applicable
law, and to the extent that Indemnitee is, by reason of his Corporate Status, a witness in any Proceeding to which Indemnitee is
not a party, he shall be indemnified against all Expenses actually and reasonably incurred by him or on his behalf in connection
therewith.

 

Section 6. Exceptions.
Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to make any indemnity
in connection with any Proceeding:

 

(a) for which payment
has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, provided that the
Company shall remain obligated in accordance with the terms hereof to provide indemnity for any excess beyond the amount paid under
any insurance policy or other indemnity provision; or

 

(b) for an accounting
of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning
of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of state statutory law or common
law; or

 

 

 

 

    	 	5	 

     

    

 

(c) in connection with
any Proceeding (or any part of any Proceeding) initiated by Indemnitee unless (i) the Board of Directors of the Company authorized
the Proceeding (or any part of any Proceeding); or (ii) the Company provides the indemnification, in its sole discretion, pursuant
to the powers vested in the Company under applicable law.

 

Section 7. Advances
of Expenses. Notwithstanding any provision of this Agreement to the contrary, the Company shall advance, to the extent not
prohibited by law, the Expenses actually and reasonably incurred by or on behalf of the Indemnitee prior to the final disposition
of any Proceeding, and such advancement shall be made within ten (10) days after the receipt by the Company of a statement or statements
requesting such advances from time to time. The Indemnitee’s right to advancement is not subject to the satisfaction of any
standard of conduct. Advances shall be unsecured and interest free. Advances shall be made without regard to Indemnitee’s
ability to repay the Expenses and without regard to Indemnitee’s ultimate entitlement to indemnification under the other
provisions of this Agreement. Advances shall include any and all reasonable Expenses incurred pursuing an action to enforce this
right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances claimed.
The Indemnitee shall qualify for advances upon the execution and delivery to the Company of this Agreement, which shall constitute
an undertaking providing that the Indemnitee undertakes to repay the advance to the extent that it is ultimately determined that
Indemnitee is not entitled to be indemnified by the Company. This Section 7 shall not apply to any claim made by Indemnitee
for which indemnity is excluded pursuant to Section 6.

 

Section 8. Procedure
for Notification and Defense of Claim.

 

(a) As a condition
precedent to the Indemnitee’s right to be indemnified or to cause the establishment of a Trust in favor of Indemnitee in
accordance with the provisions of Section 12(f) of this Agreement, Indemnitee must notify the Company in writing as soon
as practicable of any proceeding for which indemnity will or could be sought. Indemnitee shall submit to the Company a written
request, including therein or therewith such documentation and information as is reasonably available to Indemnitee and is reasonably
necessary to determine whether and to what extent Indemnitee is entitled to indemnification. The Secretary of the Company shall,
promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification.

 

(b) Subject to the
terms and conditions of any applicable insurance policy or policies, the Company will be entitled to participate in the Proceeding
at its own expense.

 

Section 9. Procedure
Upon Application for Indemnification.

 

(a) Upon written request
by Indemnitee for indemnification pursuant to the first sentence of Section 8(a), a determination, with respect to Indemnitee’s
entitlement thereto shall be made in the specific case: (i) if a Change in Control shall have occurred, by Independent Counsel
in a written opinion to the Board of Directors, a copy of which shall be delivered to Indemnitee; or (ii) if a Change in Control
shall not have occurred, (A) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board; (B)
if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written
opinion to the Board, a copy of which shall be delivered to Indemnitee; or (C) by the stockholders of the Company; and, if it is
so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after such
determination.

 

(b) Indemnitee shall
cooperate with the person, persons or entity making such determination with respect to Indemnitee’s entitlement to indemnification,
including providing to such person, persons or entity upon reasonable advance request any documentation or information which is
not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary
to such determination. Any costs or expenses (including attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating
with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as
to Indemnitee’s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless
therefrom.

 

 

 

 

    	 	6	 

     

    

 

(c) Notwithstanding
Section 2 of this Agreement, within ten (10) days after the Indemnitee’s provides written notice of his selection
of Independent Counsel, the Company shall have deliver to the Indemnitee any written objection to the selection of Independent
Counsel; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does
not meet the requirements of “Independent Counsel” as defined in Section 2 of this Agreement, and the objection
shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected
shall act as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may
not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is
without merit. If, within 20 days after the later of submission by Indemnitee of a written request for indemnification pursuant
to Section 8(a) hereof and the final disposition of the Proceeding, no Independent Counsel shall have been selected and
not objected to, the Company or the Indemnitee may petition a court of competent jurisdiction for resolution of any objection which
shall have been made by the Company to the Indemnitee’s selection of Independent Counsel and/or for the appointment as Independent
Counsel of a person selected by the Court or by such other person as the Court shall designate, and the person with respect to
whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 9(a) hereof.
Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 11(a) of this Agreement, Independent
Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of
professional conduct then prevailing).

 

Section 10. Presumptions
and Effect of Certain Proceedings.

 

(a) In making a determination
with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination shall presume
that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in
accordance with Section 8(a) of this Agreement, and the Company shall have the burden of proof to overcome that presumption
in connection with the making by any person, persons or entity of any determination contrary to that presumption. Neither the failure
of the Company (including by its directors or independent legal counsel) to have made a determination prior to the commencement
of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable
standard of conduct, nor an actual determination by the Company (including by its directors or independent legal counsel) that
Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee
has not met the applicable standard of conduct.

 

(b) The termination
of any Proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not of
itself create a presumption that Indemnitee did not act in good faith and in a manner which he reasonably believed to be in, or
not opposed to, the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause
to believe that his conduct was unlawful.

 

(c) Reliance as Safe
Harbor. For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s
action is based on the records or books of account of the Enterprise, including financial statements, or on information supplied
to Indemnitee by the officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise
or on information or records given or reports made to the Enterprise by an independent certified public accountant or by an appraiser
or other expert selected with the reasonable care by the Enterprise. The provisions of this Section 10(c) shall not be deemed
to be exclusive or to limit in any way the other circumstances in which the Indemnitee may be deemed to have met the applicable
standard of conduct set forth in this Agreement.

 

(d) Actions of Others.
The knowledge and/or actions, or failure to act, of any director, officer, agent or employee of the Enterprise shall not be imputed
to Indemnitee for purposes of determining the right to indemnification under this Agreement.

 

 

 

 

    	 	7	 

     

    

 

Section 11. Remedies
of Indemnitee.

 

(a) Subject to Section
11(d), in the event that (i) a determination is made pursuant to Section 9 of this Agreement that Indemnitee is not
entitled to indemnification under this Agreement; (ii) the advancement of Expenses it not timely made pursuant to Section 7
of this Agreement; (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 9(a)
of this Agreement within 60 days after receipt by the Company of the request for indemnification; (iv) payment of indemnification
is not made pursuant to Section 4, 5, or 6 or the last sentence of Section 9(a) of this Agreement within
ten (10) days after receipt by the Company of a written request therefore; or (v) payment of indemnification pursuant to Section
3, of this Agreement is not made within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification,
subject to Section 21, Indemnitee shall be entitled to enforce its rights under this Agreement in a court of competent jurisdiction.
Alternatively, Indemnitee, at his option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the
Commercial Arbitration Rules of the American Arbitration Association. Indemnitee shall commence such proceeding seeking an adjudication
or an award in arbitration within 180 days following the date on which Indemnitee first has the right to commence such proceeding
pursuant to this Section 11(a). The Company shall not oppose Indemnitee’s right to seek any such adjudication or award
in arbitration.

 

(b) In the event that
a determination shall have been made pursuant to Section 9(a) of this Agreement that Indemnitee is not entitled to indemnification,
any judicial proceeding or arbitration commenced pursuant to this Section 11 shall be conducted in all respects as a de
novo trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination. In any
judicial proceeding or arbitration commenced pursuant to this Section 11 the Company shall have the burden of proving Indemnitee
is not entitled to indemnification or advancement of Expenses, as the case may be.

 

(c) The Company shall
be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 11 that the procedures
and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such
arbitrator that the Company is bound by all the provisions of this Agreement. The Company shall indemnify Indemnitee against any
and all Expenses and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request
therefor) advance, to the extent not prohibited by law, such Expenses to Indemnitee, which are incurred by Indemnitee in connection
with any action brought by Indemnitee for indemnification or advance of Expenses from the Company under this Agreement or under
any directors’ and officers’ liability insurance policies maintained by the Company, regardless of whether Indemnitee
ultimately is determined to be entitled to such indemnification, advancement of Expenses or insurance recovery, as the case may
be.

 

(d) Notwithstanding
anything in this Agreement to the contrary, no determination as to entitlement to indemnification under this Agreement shall be
required to be made prior to the final disposition of the Proceeding.

 

Section 12. Non-exclusivity;
Survival of Rights; Insurance; Subrogation; Establishment of Trust.

 

(a) The rights of indemnification
and to receive advancement of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which
Indemnitee may at any time be entitled under applicable law, the Company’s Certificate of Incorporation, the Company’s
By-laws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. No amendment, alteration or repeal of
this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any
action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment, alteration or repeal. To the extent
that a change in Delaware law, whether by statute or judicial decision, permits greater indemnification or advancement of Expenses
than would be afforded currently under the Company’s Certificate of Incorporation and this Agreement, it is the intent of
the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change. No right or remedy
herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative
and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise.
The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment
of any other right or remedy.

 

 

 

 

    	 	8	 

     

    

 

(b) To the extent that
the Company maintains an insurance policy or policies providing liability insurance for directors, officers, employees, consultants,
or agents of the Company or of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise
which such person serves at the request of the Company, Indemnitee shall be covered by such policy or policies in accordance with
its or their terms to the maximum extent of the coverage available for any such director, officer, employee, consultant, or agent
under such policy or policies. If, at the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company
has director and officer liability insurance in effect, the Company shall give prompt notice of the commencement of such proceeding
to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary
or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such proceeding
in accordance with the terms of such policies. Without limiting the foregoing, the Company will use its reasonable best efforts
to maintain director and officer liability insurance in respect of acts or omissions occurring during the period of time that Indemnitee
serves or served as an officer, director, consultant, agent or employee of the Company covering Indemnitee on terms at least as
favorable as the coverage currently in effect on the date hereof, provided that in satisfying its obligation under this Section
12(b), the Company shall not be obligated to pay premiums in excess of 200% of the amount per annum the Company paid in its
last full fiscal year prior to the date hereof, and if the Company is unable to obtain the insurance required by this Section
12(b), it shall obtain as much comparable insurance as possible for an annual premium equal to such maximum amount.

 

(c) In the event of
any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery
of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of
such documents as are necessary to enable the Company to bring suit to enforce such rights.

 

(d) The Company shall
not be liable under this Agreement to make any payment of amounts otherwise indemnifiable (or for which advancement is provided
hereunder) hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy,
contract, agreement or otherwise.

 

(e) The Company’s
obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director,
officer, employee, consultant, or agent of any other corporation, limited liability company, partnership, joint venture, trust,
employee benefit plan or other enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or
advancement of expenses from such other corporation, limited liability company, partnership, joint venture, trust, employee benefit
plan or other enterprise.

 

(f) In the event of
a Potential Change in Control the Company shall, upon written request by a Director Indemnitee containing the information required
by Section 9(a) of this Agreement, create a trust (the “Trust”) for the benefit of the Director Indemnitee
and from time to time upon written request of the Director Indemnitee shall fund the Trust in an amount sufficient to satisfy any
and all amounts for which the Director Indemnitee is entitled to indemnification or advancement of Expenses hereunder that are
actually paid or that the Director Indemnitee reasonably determines from time to time may be payable by the Company under this
Agreement; provided, however, that the Company shall not be required to establish the Trust if, at the time a written request by
the Director Indemnitee is made pursuant to this Section 12(f), the Company provides the Director Indemnitee with written
evidence reasonably satisfactory to the Director Indemnitee that the Company maintains director and officer liability insurance
in respect of acts or omissions occurring during the period of time that the Director Indemnitee serves or served as an officer,
director, agent or employee of the Company covering the Director Indemnitee on terms at least as favorable as the coverage currently
in effect on the date hereof, without taking into account the limitation on premiums the Company is required to pay pursuant to
Section 12(b) of this Agreement. The amount or amounts to be deposited in the Trust pursuant to the foregoing funding obligation
(or, if applicable, the adequacy of director and officer liability insurance maintained by the Company pursuant to the proviso
to the preceding sentence) shall be determined by the applicable party specified in Section 9(a) of this Agreement. The
terms of the Trust shall provide that upon a Change in Control: (i) the Trust shall not be revoked or the principal thereof invaded
without the written consent of the Director Indemnitee; (ii) the trustee of the Trust shall advance, within ten (10) days of a
request by the Director Indemnitee, any and all Expenses to the Director Indemnitee (and the Director Indemnitee hereby agrees
to reimburse the Trust under the circumstances under which the Director Indemnitee would be required to reimburse the Company under
Section 7 of this Agreement); (iii) the Company shall continue to fund the Trust from time to time in accordance with the
funding obligations set forth above; (iv) the trustee of the Trust shall promptly pay to the Director Indemnitee all amounts and
Expenses for which the Director Indemnitee shall be entitled to indemnification pursuant to this Agreement; and (v) all unexpended
funds in the Trust shall revert to the Company upon a final determination by a court of competent jurisdiction in a final decision
from which there is no further right of appeal that the Director Indemnitee has been fully indemnified under the terms of this
Agreement. The trustee of the Trust shall be chosen by the Director Indemnitee.

 

 

 

    	 	9	 

     

    

 

Section 13. Access
to Board Papers.

 

(a) The Company agrees
to maintain a complete set of Board Papers, in a systematic and organized manner, in secure custody during the Access Period; provided,
however, that if the relevant Board Papers were created prior to the date of this Agreement, the Company shall be deemed to have
satisfied its obligations under this Section 13(a) if it uses all reasonable efforts to collate and keep those Board Papers
in the manner required hereby. Subject to the foregoing proviso and the limitation in Sections 13(b) and 13(c), if
Indemnitee asks to inspect, or for a copy of, any Board Paper during the Access Period and the request is made in connection with
any Proceedings or the threat of any Proceedings, the Company must, within fourteen (14) days after receiving that request: (i)
allow Indemnitee (or a person nominated in writing by Indemnitee) to inspect the Board Paper at the Company’s registered
office (or any other place agreed by the Company and Indemnitee), and (ii) provide Indemnitee a copy of the Board Paper without
charge.

 

(b) Indemnitee hereby
acknowledges that: (i) the Company remains the owner of all Board Papers and the Company may request Indemnitee to provide the
Company with reasons why Indemnitee requires access to a document, (ii) as a condition to Indemnitee’s right to receive any
Board Papers, Indemnitee must, on written request by the Company, provide the Company with written reasons why Indemnitee requires
access to a document, and (iii) Indemnitee must return to the Company or destroy all copies of any Board Paper obtained from the
Company under this Section 13 within ten (10) days after the relevant Proceedings are finally resolved or the threat of
such Proceedings has ceased to materially exist.

 

(c) If the Company
has any right (including a right it has jointly or in common with Indemnitee or with Indemnitee and others) to privilege, such
as attorney-client privilege, with respect to any document which Indemnitee inspects, copies or uses under this Agreement or the
DGCL: (i) that document is to be treated by Indemnitee as confidential; (ii) by permitting the inspection, copying or use to Indemnitee
or Indemnitee’s permitted nominee, the Company does not waive any privilege; and (iii) in so inspecting, copying or using
the document by himself or herself or through Indemnitee’s permitted nominee, Indemnitee must use his or her best efforts
to ensure that so far as is practical the right to privilege is not lost or waived, whether by Indemnitee or the Indemnitee’s
nominee or otherwise and as a condition to providing any such document to Indemnitee the Company may require Indemnitee to enter
into a reasonable and customary joint defense or other similar agreement for the protection of any such privilege. Nothing in this
Agreement shall be deemed to prevent or preclude the Company from relying on privilege in proceedings between Indemnitee and the
Company (including in respect of a document which the Company has disclosed to Indemnitee outside those proceedings).

 

(d) Nothing in this
Section 13 shall be deemed to limit any right of access Indemnitee otherwise has to Board Papers.

 

(e) Indemnitee hereby
agrees not to disclose any confidential information contained in a Board Paper to a third party unless: (i) the Company has given
its prior written consent to such disclosure; (ii) Indemnitee is required to do so by law; (iii) the disclosure is made for the
purpose of obtaining professional advice or in connection with the relevant Proceedings or the threat of such Proceedings in relation
to which Indemnitee was given access to the Board Paper; or (iv) the disclosure is made on behalf of the Company and for Company
purposes in furtherance of Indemnitee’s duties as a director, officer, employee or agent of the Company at the time such
disclosure is made; provided, however, if Indemnitee is entitled to disclose confidential information under this Section 13(e)
and the Board Papers include any information to which attorney-client privilege attaches for the benefit of the Company, or both
the Company and Indemnitee, Indemnitee must use his or her best efforts to avoid doing anything that will cause that privilege
to be waived, extinguished or lost by the Company in relation to third parties.

 

Section 14. Duration
of Agreement. This Agreement shall continue until and terminate upon the later of: (a) ten years after the date that Indemnitee
shall have ceased to serve as a director, officer, consultant, agent, or employee of the Company or (b) one year after the final
termination of any Proceeding then pending in respect of which Indemnitee is granted rights of indemnification or advancement of
Expenses hereunder and of any proceeding commenced by Indemnitee pursuant to Section 11 of this Agreement relating thereto.
This Agreement shall be binding upon the Company and its successors and assigns and shall inure to the benefit of Indemnitee and
his heirs, executors and administrators.

 

 

 

 

    	 	10	 

     

    

 

Section 15. Severability.
If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever:
(a) the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, each
portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not
itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to
the fullest extent permitted by law; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform
to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the
provisions of this Agreement (including, without limitation, each portion of any Section of this Agreement containing any such
provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed
so as to give effect to the intent manifested thereby.

 

Section 16. Enforcement.

 

(a) The Company expressly
confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce
Indemnitee to serve or continue to serve as a director or officer of the Company, and the Company acknowledges that Indemnitee
is relying upon this Agreement in serving as a director, officer, or consultant of the Company.

 

(b) This Agreement
is a supplement to and in furtherance of the Certificate of Incorporation of the Company, the By-laws of the Company and applicable
law, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder or under any
other prior written agreement to which the Company or its predecessors, on the one hand, and Indemnitee and his or her affiliates,
on the other, are a party.

 

Section 17. Modification
and Waiver. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the parties
thereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions
of this Agreement nor shall any waiver constitute a continuing waiver.

 

Section 18. Notice
by Indemnitee. Indemnitee agrees promptly to notify the Company in writing upon being served with any summons, citation, subpoena,
complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification
or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company shall not relieve the Company
of any obligation which it may have to the Indemnitee under this Agreement or otherwise.

 

Section 19. Notices.
All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been
duly given if (a) delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed;
(b) mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed;
(c) mailed by reputable overnight courier and receipted for by the party to whom said notice or other communication shall have
been directed; or (d) sent by facsimile transmission, with receipt of oral confirmation that such transmission has been received:

 

(a) If to Indemnitee,
at the address indicated on the signature page of this Agreement, or such other address as Indemnitee shall provide to the Company.

 

(b) If to the Company
to:

 

Mosaic ImmunoEngineering
Inc.

Attn: Steven King,
President and CEO

19881 Brookhurst Street,
C-245

Huntington Beach, CA
92646

 

or to any other address
as may have been furnished to Indemnitee by the Company.

 

 

 

 

    	 	11	 

     

    

 

Section 20. Contribution.
To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to
Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred
by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses,
in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and
reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the
Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding; and/or (ii) the relative
fault of the Company (and its directors, officers, employees, consultants, and agents) and Indemnitee in connection with such event(s)
and/or transaction(s).

 

Section 21. Applicable
Law and Consent to Jurisdiction. This Agreement and the legal relations among the parties shall be governed by, and construed
and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. Except with respect
to any arbitration commenced by Indemnitee pursuant to Section 13(a) of this Agreement, the Company and Indemnitee hereby
irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in connection with this Agreement shall
be brought only in the Chancery Court of the State of Delaware (the “Delaware Court”), and not in any other
state or federal court in the United States of America or any court in any other country; (ii) consent to submit to the exclusive
jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement;
(iii) appoint irrevocably, to the extent such party is not otherwise subject to service of process in the State of Delaware, United
States Corporation Agents, Inc., 300 Delaware Avenue, Suite 210-A, Wilmington, Delaware, 19801, as its agent in the State of Delaware
as such party’s agent for acceptance of legal process in connection with any such action or proceeding against such party
with the same legal force and validity as if served upon such party personally within the State of Delaware; (iv) waive any objection
to the laying of venue of any such action or proceeding in the Delaware Court; and (v) waive, and agree not to plead or to make,
any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum.

 

Section 22. Identical
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to
be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party
against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.

 

Section 23. Miscellaneous.
Use of the masculine pronoun shall be deemed to include usage of the feminine pronoun where appropriate. The headings of the paragraphs
of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the
construction thereof.

 

IN WITNESS WHEREOF,
the parties have caused this Agreement to be signed as of the day and year first above written.

 

	
        MOSAIC IMMUNOENGINEERING INC.

         

         

         

         

        By: _____________________________________________

         

        Name:

         

        Title:

         

         
	 	
        INDEMNITEE

         

         

         

         

        By: _____________________________________________

         

        Name:

         

        Title:

 

 

 

 

 

    	 	12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}]]